Boston Common Asset Management, LLC Astellas Pharma Inc Unsponsore Transaction History

Boston Common Asset Management, LLC

  • $3.84 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 06, 2018
SELL
N/A
-69,038 Closed
0 $0
Q1 2018

Apr 26, 2018
SELL
N/A
-8,387 Reduced 10.83%
69,038 $1.05 Million
Q4 2017

Feb 07, 2018
BUY
N/A
6,318 Added 8.89%
77,425 $988,000
Q3 2017

Nov 13, 2017
BUY
N/A
542 Added 0.77%
71,107 $904,000
Q2 2017

Aug 14, 2017
BUY
N/A
70,565
70,565 $863,000

Others Institutions Holding ALPMY

# of Institutions
5
Shares Held
208K
Call Options Held
0
Put Options Held
0
View Full List

About Astellas Pharma Inc Unsponsore

ALPMY Quotes by TradingView
  • Ticker ALPMY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,827,069,952
  • Market Cap $17.9B
More about ALPMY
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email